In an ensuing discussion with officials on the White House’s coronavirus task force, Teva positioned itself as a valuable partner in the manufacturing and distribution of potential medical treatments for the coronavirus, according to people familiar with the discussions, who weren’t authorized to speak publicly about them. (In the weeks since, the results of several studies have dampened enthusiasm for hydroxychloroquine, and Mr. Trump has stopped emphasizing the drug.)

Source: New York Times May 15, 2020 15:00 UTC